<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:entx="http://www.enterabio.com/20260930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="entx-20260930.xsd" xlink:type="simple"/>
    <context id="C_20260930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260728_usgaapClassOfWarrantOrRightAxis_entxPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">entx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-28</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20250930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20260401to20260401_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-04-01</endDate>
        </period>
    </context>
    <context id="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="C_20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="C_20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="C_20260401_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-01</instant>
        </period>
    </context>
    <context id="C_20260701to20260731_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="C_20260731_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-31</instant>
        </period>
    </context>
    <context id="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-28</startDate>
            <endDate>2026-07-28</endDate>
        </period>
    </context>
    <context id="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-28</startDate>
            <endDate>2026-07-28</endDate>
        </period>
    </context>
    <context id="C_20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-28</instant>
        </period>
    </context>
    <context id="C_20260821_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-21</instant>
        </period>
    </context>
    <context id="C_20260728_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-28</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:April2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260821_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-21</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:July2026PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">entx:InstitutionalAndAccreditedInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-28</startDate>
            <endDate>2026-07-28</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementBusinessSegmentsAxis_entxSingleReportableSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">entx:SingleReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:OpkoBiologicsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-11</startDate>
            <endDate>2025-03-16</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:OpkoBiologicsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:OpkoBiologicsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260101_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:FiveNonExecutiveMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-01</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260201to20260228_srtTitleOfIndividualAxis_entxFormerNonExecutiveBoardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:FormerNonExecutiveBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="C_20260930_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20251231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-07-14</instant>
        </period>
    </context>
    <context id="C_20260807to20260807_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:FiveNonExecutiveMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260714to20260714_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-14</startDate>
            <endDate>2026-07-14</endDate>
        </period>
    </context>
    <context id="C_20260501to20260501_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-01</endDate>
        </period>
    </context>
    <context id="C_20260916to20260916_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-16</startDate>
            <endDate>2026-09-16</endDate>
        </period>
    </context>
    <context id="C_20261102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-11-02</instant>
        </period>
    </context>
    <unit id="NIS_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>entx:Segment</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_20260101to20260930"
      id="Fdei_EntityCentralIndexKey20220219150840900">0001638097</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20260101to20260930"
      id="Fdei_AmendmentFlag20220219150858854">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20260101to20260930"
      id="Fdei_DocumentFiscalPeriodFocus20220219151109286">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20260101to20260930"
      id="Fdei_CurrentFiscalYearEndDate20220506104715921">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_20260101to20260930_usgaapStatementBusinessSegmentsAxis_entxSingleReportableSegmentMember"
      decimals="0"
      id="Fxbrl_20260804213019803"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_20260101to20260930_usgaapStatementBusinessSegmentsAxis_entxSingleReportableSegmentMember"
      decimals="0"
      id="Fxbrl_20260804213855092"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260930"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250930"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20251107164113212"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260701to20260930"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20261106032913895"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_20260101to20260930"
      id="F20230807213857684_19">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType
      contextRef="C_20260101to20260930"
      id="Fxbrl_20231101130936027">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="C_20260101to20260930" id="F20230807213857678_1">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20260101to20260930"
      id="F20230807213857685_25">2026-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20260101to20260930"
      id="F20230807213857685_26">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_20260101to20260930" id="F20230807213857679_2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_20260101to20260930" id="F20230807213857679_3">001-38556</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260501204020610">ENTERA BIO LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20260101to20260930"
      id="F20230807213857684_18">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="C_20260101to20260930" id="F20230807213857679_4">Kiryat Hadassah</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_20260101to20260930" id="F20230807213857679_5">Minrav Building &#x2013; Fifth Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_20260101to20260930" id="F20230807213857680_6">Jerusalem</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="C_20260101to20260930"
      id="F20230807213857683_17">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260101to20260930"
      id="Fxbrl_20241103190453128_20230807213857680_7">9112002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_20260101to20260930" id="F20230807213857681_8">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_20260101to20260930" id="F20230807213857682_9">2-532-7151</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_20260101to20260930"
      id="Fxbrl_20240507011622543">Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20260101to20260930"
      id="Fxbrl_20241103190453129_20230807213857682_11">ENTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20260101to20260930"
      id="Fxbrl_20240802153127672">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20260101to20260930"
      id="F20230807213857685_24">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260501204045660">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20260101to20260930"
      id="Fxbrl_20231101131214875">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_20260101to20260930"
      id="Fxbrl_20241103190453133_xbrl_20231101130810468">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20260101to20260930"
      id="Fxbrl_20241103190453134_20230807213857683_16">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="C_20260101to20260930"
      id="F20230807213857685_22">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20261102"
      decimals="INF"
      id="Fxbrl_20260506092608052"
      unitRef="shares">174137771</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429362_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_33"
      unitRef="USD">265883000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429362_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_37"
      unitRef="USD">7108000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250506012844619"
      unitRef="USD">6536000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250506012853875"
      unitRef="USD">7775000</us-gaap:RestrictedCash>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429378_xbrl_20240506175250775_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_33"
      unitRef="USD">4046000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429378_xbrl_20240506175250775_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_37"
      unitRef="USD">415000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429383_xbrl_20220808213205268_xbrl_20220802012333953_xbrl_20220505162133436_xbrl_20220219060830028_63"
      unitRef="USD">276465000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429383_xbrl_20220808213205268_xbrl_20220802012333953_xbrl_20220505162133436_xbrl_20220219060830028_67"
      unitRef="USD">15298000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429392_xbrl_20220808213205274_xbrl_20220802012333958_xbrl_20220505162133439_xbrl_20220219060830028_83"
      unitRef="USD">133000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429392_xbrl_20220808213205274_xbrl_20220802012333958_xbrl_20220505162133439_xbrl_20220219060830028_87"
      unitRef="USD">134000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429406_xbrl_20220808213205277_xbrl_20220802012333963_xbrl_20220505162133441_xbrl_20220219060830028_93"
      unitRef="USD">343000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429406_xbrl_20220808213205277_xbrl_20220802012333963_xbrl_20220505162133441_xbrl_20220219060830028_97"
      unitRef="USD">465000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250506012955555"
      unitRef="USD">93000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250506013004546"
      unitRef="USD">90000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429435_xbrl_20220808213205284_xbrl_20220802012333974_xbrl_20220505162133446_xbrl_20220219060830028_103"
      unitRef="USD">6000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429435_xbrl_20220808213205284_xbrl_20220802012333974_xbrl_20220505162133446_xbrl_20220219060830028_107"
      unitRef="USD">6000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429445_xbrl_20220808213205287_xbrl_20220802012333980_xbrl_20220505162133448_xbrl_20220219060830028_113"
      unitRef="USD">575000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429445_xbrl_20220808213205287_xbrl_20220802012333980_xbrl_20220505162133448_xbrl_20220219060830028_117"
      unitRef="USD">695000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429462_xbrl_20220808213205289_xbrl_20220802012333985_xbrl_20220505162133450_xbrl_20220219060830028_123"
      unitRef="USD">277040000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429462_xbrl_20220808213205289_xbrl_20220802012333985_xbrl_20220505162133450_xbrl_20220219060830028_127"
      unitRef="USD">15993000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429468_xbrl_20220808213205292_xbrl_20220802012333989_xbrl_20220505162133452_xbrl_20220219060830028_153"
      unitRef="USD">406000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429468_xbrl_20220808213205292_xbrl_20220802012333989_xbrl_20220505162133452_xbrl_20220219060830028_157"
      unitRef="USD">448000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429476_xbrl_20220808213205294_xbrl_20220802012333994_xbrl_20220505162133454_xbrl_20220219060830028_163"
      unitRef="USD">1540000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429476_xbrl_20220808213205294_xbrl_20220802012333994_xbrl_20220505162133454_xbrl_20220219060830028_167"
      unitRef="USD">1525000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429483_xbrl_20220808213205297_xbrl_20220802012333998_xbrl_20220505162133457_xbrl_20220219060830028_173"
      unitRef="USD">207000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429483_xbrl_20220808213205297_xbrl_20220802012333998_xbrl_20220505162133457_xbrl_20220219060830028_177"
      unitRef="USD">230000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429490_xbrl_20220808213205301_xbrl_20220802012334009_xbrl_20220505162133460_xbrl_20220219060830028_193"
      unitRef="USD">2153000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429490_xbrl_20220808213205301_xbrl_20220802012334009_xbrl_20220505162133460_xbrl_20220219060830028_197"
      unitRef="USD">2203000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429496_xbrl_20230731132348860_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD">190000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429496_xbrl_20230731132348860_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD">260000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250506013228511"
      unitRef="USD">378000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250506013239493"
      unitRef="USD">393000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD">37000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD">36000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429511_xbrl_20220808213205308_xbrl_20220802012334025_xbrl_20220505162133467_xbrl_20220219060830028_233"
      unitRef="USD">605000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429511_xbrl_20240506175318992"
      unitRef="USD">689000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429518_xbrl_20220808213205310_xbrl_20220802012334031_xbrl_20220505162133469_xbrl_20220219060830028_243"
      unitRef="USD">2758000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429518_xbrl_20220808213205310_xbrl_20220802012334031_xbrl_20220505162133469_xbrl_20220219060830028_247"
      unitRef="USD">2892000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20260930"
      id="Fxbrl_20260803152540223_xbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20251231"
      id="Fxbrl_20260803152540223_xbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20220809034950441"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20220808214817829"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20261031094959314"
      unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20220808214936276"
      unitRef="shares">140010000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20250506013325802"
      unitRef="shares">173922428</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20220808215259598"
      unitRef="shares">173922428</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_s_20251107004543855"
      unitRef="shares">46178630</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20251107004543855"
      unitRef="shares">46178630</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20220808213249447"
      unitRef="USD">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20220808214617486"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429530_xbrl_20220808213205314_xbrl_20220802012334039_xbrl_20220505162133472_xbrl_20220219060830028_283"
      unitRef="USD">426016000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429530_xbrl_20220808213205314_xbrl_20220802012334039_xbrl_20220505162133472_xbrl_20220219060830028_287"
      unitRef="USD">138425000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429539_xbrl_20220808213205316_xbrl_20220802012334043_xbrl_20220505162133474_xbrl_20220219060830028_293"
      unitRef="USD">41000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429539_xbrl_20220808213205316_xbrl_20220802012334043_xbrl_20220505162133474_xbrl_20220219060830028_297"
      unitRef="USD">41000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429546_xbrl_20230731132604195"
      unitRef="USD">-151780000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429546_xbrl_20220808213205318_xbrl_20220802012334047_xbrl_20220505162133476_xbrl_20220219060830028_307"
      unitRef="USD">-125366000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429554_xbrl_20220808213205320_xbrl_20220802012334050_xbrl_20220505162133478_xbrl_20220219060830028_313"
      unitRef="USD">274282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429554_xbrl_20220808213205320_xbrl_20220802012334050_xbrl_20220505162133478_xbrl_20220219060830028_317"
      unitRef="USD">13101000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103165429563_xbrl_20220808213205323_xbrl_20220802012334055_xbrl_20220505162133480_xbrl_20220219060830028_323"
      unitRef="USD">277040000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429563_xbrl_20220808213205323_xbrl_20220802012334055_xbrl_20220505162133480_xbrl_20220219060830028_327"
      unitRef="USD">15993000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034286_xbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034286_xbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802123117231"
      unitRef="USD">42000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802123117231"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034289_xbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034289_xbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802123117231"
      unitRef="USD">42000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802123117231"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034292_xbrl_20250802063145931_xbrl_20241103170649932_xbrl_20240802124336495_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034292_xbrl_20250802063145931_xbrl_20250802063020103"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802063145931_xbrl_20241103170649932_xbrl_20240802124336495_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802063145931_xbrl_20250802063020103"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034294_xbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802122721947"
      unitRef="USD">10377000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034294_xbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802123117231"
      unitRef="USD">4286000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802122721947"
      unitRef="USD">4925000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802123117231"
      unitRef="USD">1643000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034297_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">4990000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034297_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">4201000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">2340000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">1613000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034300_xbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">15367000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034300_xbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">8487000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">7265000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">3256000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034303_xbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-15367000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034303_xbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-8487000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-7265000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-3256000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034306_xbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802122812921"
      unitRef="USD">-11047000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034306_xbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802123155891"
      unitRef="USD">64000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802122812921"
      unitRef="USD">-8332000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802123155891"
      unitRef="USD">56000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803101034309_xbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-26414000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803101034309_xbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-8423000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-15597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-3200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20260803182533523"
      unitRef="USD_per_Share">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20260803182526419"
      unitRef="USD_per_Share">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250101to20250930"
      decimals="2"
      id="Fxbrl_s_20260803182619604"
      unitRef="USD_per_Share">0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250101to20250930"
      decimals="2"
      id="Fxbrl_20260803182619604"
      unitRef="USD_per_Share">0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_s_20260803182635493"
      unitRef="USD_per_Share">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_20260803182635493"
      unitRef="USD_per_Share">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250701to20250930"
      decimals="2"
      id="Fxbrl_s_20260803182650864"
      unitRef="USD_per_Share">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250701to20250930"
      decimals="2"
      id="Fxbrl_20260803182650864"
      unitRef="USD_per_Share">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20260804202656542"
      unitRef="shares">81207725</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20260803182914853"
      unitRef="shares">81207725</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250101to20250930"
      decimals="INF"
      id="Fxbrl_s_20260803182940275"
      unitRef="shares">45829501</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20250101to20250930"
      decimals="INF"
      id="Fxbrl_20260803182940276"
      unitRef="shares">45829501</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260701to20260930"
      decimals="INF"
      id="Fxbrl_s_20260803183020058"
      unitRef="shares">145075070</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20260701to20260930"
      decimals="INF"
      id="Fxbrl_20260803183020058"
      unitRef="shares">145075070</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250701to20250930"
      decimals="INF"
      id="Fxbrl_s_20260803183049033"
      unitRef="shares">47089814</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20250701to20250930"
      decimals="INF"
      id="Fxbrl_20260803183049034"
      unitRef="shares">47089814</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_66"
      unitRef="shares">46178630</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808214535386"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802162836869"
      unitRef="USD">138425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_63"
      unitRef="USD">-125366000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_62"
      unitRef="USD">13101000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-26414000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-26414000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">410308</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">288000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">288000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfWarrantsAndPreFundedWarrantsShares
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">1387765</entx:ExerciseOfWarrantsAndPreFundedWarrantsShares>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">474000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">474000</us-gaap:ProceedsFromWarrantExercises>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">125386215</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">227413000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">227417000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:ReclassificationOfPreFundedWarrantsToEquityShares
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">0</entx:ReclassificationOfPreFundedWarrantsToEquityShares>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">55703000</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">55703000</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">302868</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <entx:SettlementInShareOfBoardMembersCompensationShares
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">256642</entx:SettlementInShareOfBoardMembersCompensationShares>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">598000</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">598000</entx:SettlementInShareOfBoardMembersCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250506041923331"
      unitRef="USD">3115000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20250506041944631"
      unitRef="USD">3115000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">173922428</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">426016000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-151780000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">274282000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_66"
      unitRef="shares">49290233</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808214535386"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_65"
      unitRef="USD">143407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_63"
      unitRef="USD">-136183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_62"
      unitRef="USD">7266000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-15597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-15597000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">15560</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">28000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">28000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfWarrantsAndPreFundedWarrantsShares
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">1387765</entx:ExerciseOfWarrantsAndPreFundedWarrantsShares>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">474000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">474000</us-gaap:ProceedsFromWarrantExercises>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">122961215</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">224276000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">224280000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:ReclassificationOfPreFundedWarrantsToEquityShares
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">0</entx:ReclassificationOfPreFundedWarrantsToEquityShares>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">55703000</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:ReclassificationOfPreFundedWarrantsToEquityValue
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">55703000</entx:ReclassificationOfPreFundedWarrantsToEquityValue>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">159885</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <entx:SettlementInShareOfBoardMembersCompensationShares
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031105027141_xbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="shares">107770</entx:SettlementInShareOfBoardMembersCompensationShares>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20261106033136429"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031105027141_xbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">309000</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261106033139720"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261106033143308"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20261031105027141_xbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">309000</entx:SettlementInShareOfBoardMembersCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041923331"
      unitRef="USD">1819000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041929267"
      unitRef="USD">1819000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">173922428</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">426016000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-151780000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">274282000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">38837220</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">121965000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-113927000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">8080000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-8423000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-8423000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfWarrantsShares
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">353292</entx:ExerciseOfWarrantsShares>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">354000</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">354000</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">1125</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">1000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">1000</entx:ExerciseOfOptionsValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">3685226</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">7115000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">7115000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">2731574</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">6067000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">6067000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">56069</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041923331"
      unitRef="USD">2040000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041935570"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041944631"
      unitRef="USD">2040000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">45664506</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">137542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-122350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">15234000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">45452167</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">136364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-119150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">17256000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-3200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-3200000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfWarrantsShares
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">179640</entx:ExerciseOfWarrantsShares>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">180000</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">180000</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">1125</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">1000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">1000</entx:ExerciseOfOptionsValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">31574</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">70000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">70000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041923331"
      unitRef="USD">927000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041935570"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041944631"
      unitRef="USD">927000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">45664506</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">137542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-122350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250930"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">15234000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541059_xbrl_20220219041121835_33"
      unitRef="USD">-26414000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541059_xbrl_20220219041121835_37"
      unitRef="USD">-8423000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541067_xbrl_20220219041121835_63"
      unitRef="USD">25000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541067_xbrl_20220219041121835_67"
      unitRef="USD">23000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">3115000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">2040000</us-gaap:ShareBasedCompensation>
    <entx:FinanceIncomeExpensesNet
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803112148836_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">-11000</entx:FinanceIncomeExpensesNet>
    <entx:FinanceIncomeExpensesNet
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803112148836_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">8000</entx:FinanceIncomeExpensesNet>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260804203455042"
      unitRef="USD">-10289000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260804203528849"
      unitRef="USD">0</us-gaap:OtherNoncashIncomeExpense>
    <entx:IssuanceCost
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803114946389_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">-2094000</entx:IssuanceCost>
    <entx:IssuanceCost
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803114946389_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">0</entx:IssuanceCost>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541093_xbrl_20220219041121835_133"
      unitRef="USD">3631000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541093_xbrl_20220219041121835_137"
      unitRef="USD">219000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803114951021_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803114951021_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">-126000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175555825_xbrl_20220802102026794"
      unitRef="USD">-42000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175555825_xbrl_20230731140959224"
      unitRef="USD">84000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175600530_xbrl_20220219041121835_153"
      unitRef="USD">600000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175600530_xbrl_20220219041121835_157"
      unitRef="USD">840000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541103_xbrl_20220219041121835_173"
      unitRef="USD">-13953000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541103_xbrl_20220305111416980"
      unitRef="USD">-5537000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541109_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">24000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541109_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">80000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541116_xbrl_20221030215741538"
      unitRef="USD">-24000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541116_xbrl_20221030215753542"
      unitRef="USD">-80000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803114959840_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">285000000</entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants>
    <entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803114959840_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">0</entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541124_xbrl_20240802134235311_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541124_xbrl_20240802134235311_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">6254000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20250506041406242"
      unitRef="USD">14262000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20250506041411832"
      unitRef="USD">262000</us-gaap:PaymentsOfStockIssuanceCosts>
    <entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20250506041435220"
      unitRef="USD">0</entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement>
    <entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20250506041440476"
      unitRef="USD">7190000</entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement>
    <entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260803115004003_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">762000</entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares>
    <entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260803115004003_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">354000</entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541167_xbrl_20230731140302926_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">271500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541167_xbrl_20230731140302926_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">13536000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541181_xbrl_20220219041121835_313"
      unitRef="USD">257523000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541181_xbrl_20220219041121835_317"
      unitRef="USD">7919000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260804204136954"
      unitRef="USD">16000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260804204205115"
      unitRef="USD">29000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103175541190_xbrl_20240506221453069_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">14973000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20241103175541190_xbrl_20240506221453069_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">8740000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103175541196_xbrl_20230426031130941"
      unitRef="USD">272512000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250930"
      decimals="-3"
      id="Fxbrl_20241103175541196_xbrl_20230426031137438"
      unitRef="USD">16688000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103175541202_xbrl_20220505171612811"
      unitRef="USD">265883000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20250930"
      decimals="-3"
      id="Fxbrl_20241103175541202_xbrl_20220505171631694"
      unitRef="USD">8574000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250802063337635"
      unitRef="USD">6629000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_20250930"
      decimals="-3"
      id="Fxbrl_20241103175541209_xbrl_20230426031246543"
      unitRef="USD">8114000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103175541216_xbrl_20240506221327972_xbrl_20230426031237262"
      unitRef="USD">272512000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250930"
      decimals="-3"
      id="Fxbrl_20241103175541216_xbrl_20240506221327972_xbrl_20230426031246543"
      unitRef="USD">16688000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <entx:InterestReceived
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20241103175541223_xbrl_20240506215335901_xbrl_20230731140755339_xbrl_20230426031237262"
      unitRef="USD">1431000</entx:InterestReceived>
    <entx:InterestReceived
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20241103175541223_xbrl_20240506215335901_xbrl_20230731140755339_xbrl_20230426031246543"
      unitRef="USD">126000</entx:InterestReceived>
    <entx:ReclassificationOfPreFundedWarrantsLiabilityToEquity
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261031102956643_xbrl_20241103175541202_xbrl_20220505171612811"
      unitRef="USD">55703000</entx:ReclassificationOfPreFundedWarrantsLiabilityToEquity>
    <entx:ReclassificationOfPreFundedWarrantsLiabilityToEquity
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20261031102956643_xbrl_20241103175541202_xbrl_20220505171631694"
      unitRef="USD">0</entx:ReclassificationOfPreFundedWarrantsLiabilityToEquity>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261031102958771_xbrl_20241103175541202_xbrl_20220505171612811"
      unitRef="USD">38000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20261031102958771_xbrl_20241103175541202_xbrl_20220505171631694"
      unitRef="USD">59000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20241103181931773">
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;NOTE 1 - DESCRIPTION OF BUSINESS&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

        &lt;tr style="vertical-align:top"&gt;
          &lt;td style="width:7.05pt"&gt;&lt;/td&gt;
          &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Entera Bio Ltd. (collectively with its subsidiary, the "Company" or &#x201c;Entera&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;) was incorporated on September 30, 2009 and commenced operation on June 1, 2010. On January 8, 2018, the Company incorporated its wholly owned subsidiary, Entera Bio Inc., in Delaware, United States.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is focused on developing first-in-class oral peptides. The Company focuses on underserved, chronic medical conditions for which oral administration of a protein therapy has the potential to significantly shift a treatment paradigm.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s most advanced product candidate, EB613, oral PTH(1-34), is being developed as the first oral, osteoanabolic (bone building) tablet treatment for post-menopausal women with osteoporosis. In February 2026, the Company submitted to the U.S. Food and Drug Administration (the &#x201c;FDA&#x201d;) a clinical amendment which included the EB613 Phase 3 protocol, statistical analysis plan and open-label extension synopsis. In June 2026, the Company received feedback from the FDA on the submitted Phase 3 registrational plan for EB613.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s second product candidate, EB612, is being developed as the first oral acylated PTH(1-34) protein replacement tablet for patients with hypoparathyroidism. In February 2026, the Company amended and restated the 2025 Collaboration Agreement (as defined in Note 6) with OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (&#x201c;OPKO&#x201d;), to advance this program jointly. Currently, the Company is advancing EB612 through IND-enabling studies and plans to initiate a Phase 1 Single Ascending Dose (SAD) study in 2027.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, EB618 is being developed pursuant to the Company&#x2019;s collaboration with OPKO, pursuant to which the companies are advancing a proprietary novel dual agonist GLP-1/glucagon peptide as a potential once-daily tablet treatment for patients with obesity, metabolic and fibrotic disorders.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition to its internal product development programs, the Company intends to license its proprietary N-Tab&lt;sup&gt;&#xae;&lt;/sup&gt; platform to biopharmaceutical companies for use with their proprietary compounds.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

        &lt;tr style="vertical-align:top"&gt;
          &lt;td style="width:7.1pt"&gt;&lt;/td&gt;
          &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's ordinary shares, NIS 0.0000769 par value per share (&#x201c;ordinary shares&#x201d;), are listed on the Nasdaq Capital Market under the symbol &#x201c;ENTX&#x201d;.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

        &lt;tr style="vertical-align:top"&gt;
          &lt;td style="width:7.1pt"&gt;&lt;/td&gt;
          &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has incurred recurring operating losses and negative cash flows from operations since inception and expects to continue to incur operating losses as it advances the development of its product candidates. As of September 30, 2026, the Company has incurred an accumulated deficit in the amount of $151.8 million.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;As described in Note 3b, on July 28, 2026, the Company completed a private placement financing (the "July 2026 Private Placement") of an aggregate of 134,803,910 ordinary shares and pre-funded warrants to purchase ordinary shares, resulting in net proceeds of approximately $260.9 million, after deducting issuance costs. The Company expects to use the net proceeds primarily to support activities related to the initiation of its Phase 3 registrational study of EB613, as well as for general working capital and corporate purposes.&lt;/p&gt;
    &lt;div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/div&gt;
    &lt;div style="margin-top:0px;margin-bottom:0px"&gt;&lt;/div&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Based on the Company's current operating plan, management believes that its existing cash and cash equivalents will be sufficient to fund its planned operations for at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

        &lt;tr style="vertical-align:top"&gt;
          &lt;td style="width:7.1pt"&gt;&lt;/td&gt;
          &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Since October 2023, Israel has been involved in an armed conflict with Hamas, which has expanded to include hostilities involving Hezbollah, Iran and other armed groups in the region. During 2026, military activity escalated, including direct military exchanges involving Israel, Iran and the United States, as well as renewed hostilities along Israel's northern border. A ceasefire between the United States and Iran that was formalized in June 2026 subsequently broke down, and hostilities between the United States and Iran resumed beginning in late June 2026. Although ceasefire arrangements have been announced from time to time, the regional security situation remains uncertain, and there can be no assurance that hostilities will not continue or further escalate.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's research personnel and&#160;certain members of management are located in Israel, while its clinical, regulatory and supply chain activities are primarily conducted outside Israel. As of September 30, 2026, the Company's operations have remained largely unaffected by these events. For the nine months ended September 30, 2026 and 2025, and for the year ended December 31, 2025, the impact of these events on the Company's results of operations and financial condition was not material.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20260930"
      decimals="7"
      id="Fxbrl_20230731131108454"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20260930"
      decimals="-5"
      id="Fxbrl_20260804204850772"
      unitRef="USD">-151800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20260701to20260728_usgaapClassOfWarrantOrRightAxis_entxPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260804204922397"
      unitRef="shares">134803910</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260701to20260728_usgaapClassOfWarrantOrRightAxis_entxPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261031111833146"
      unitRef="USD">260900000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250802062623723">
    &lt;div&gt;
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;a.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basis of presentation of the financial statements&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s consolidated financial position as of September 30, 2026, the consolidated results of operations and statements of changes in shareholders' equity for the three and nine months ended September 30, 2026 and 2025, and cash flows for the nine months ended September 30, 2026 and 2025.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated results of operations for the three and nine months ended September 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company as of and for the year ended December 31, 2025, as filed with the Company&#x2019;s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 27, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;

        &lt;p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/p&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;/span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Loss per share &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic loss per share is computed on the basis of net loss for the period divided by the weighted average number of outstanding ordinary shares, equity classified pre-funded warrants and vested restricted share units (&#x201c;RSUs&#x201d;) during the period. Each outstanding pre-funded warrant has no expiration and is exercisable at an exercise price of $0.000025 per ordinary share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 71.45pt;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per share is based upon the weighted average number of ordinary shares and ordinary share equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, liability classified pre-funded warrants, warrants and RSUs, which are included under the treasury stock method when dilutive. The calculation of diluted loss per share did not include options, liability classified pre-funded warrants, warrants and RSUs exercisable into 29,411,128 ordinary shares and 17,016,053 ordinary shares for the nine months ended September 30, 2026 and 2025, respectively, and 36,219,126 ordinary shares and 17,806,128 ordinary shares for the three months ended September 30, 2026 and 2025, respectively, because the effect would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;

        &lt;p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;c.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0pt 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 1in;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Calibri, Helvetica, Sans-Serif;width:100%;border-collapse:separate"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:42.55pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:42.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Level 1:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Calibri, Helvetica, Sans-Serif;width:100%;border-collapse:separate"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:42.55pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:42.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Level 2:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Observable prices that are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Calibri, Helvetica, Sans-Serif;width:100%;border-collapse:separate"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:42.55pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:42.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Level 3:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/p&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;d.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Newly issued and recently adopted accounting pronouncements:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;i&gt;Recently issued accounting pronouncements not yet adopted&lt;/i&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 1in;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In November 2024, the FASB issued ASU&#160;2024-03 &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#x201d;, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 1in;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In December 2025, the FASB issued ASU 2025-10 &#x201c;Government Grants (Topic 832)&#x201d; to establish authoritative guidance on the accounting for government grants received by business entities. This update is effective beginning with the Company&#x2019;s 2029 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260501154955780">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;a.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basis of presentation of the financial statements&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s consolidated financial position as of September 30, 2026, the consolidated results of operations and statements of changes in shareholders' equity for the three and nine months ended September 30, 2026 and 2025, and cash flows for the nine months ended September 30, 2026 and 2025.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated results of operations for the three and nine months ended September 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company as of and for the year ended December 31, 2025, as filed with the Company&#x2019;s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 27, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260501155004613">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;/span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Loss per share &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic loss per share is computed on the basis of net loss for the period divided by the weighted average number of outstanding ordinary shares, equity classified pre-funded warrants and vested restricted share units (&#x201c;RSUs&#x201d;) during the period. Each outstanding pre-funded warrant has no expiration and is exercisable at an exercise price of $0.000025 per ordinary share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 71.45pt;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per share is based upon the weighted average number of ordinary shares and ordinary share equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, liability classified pre-funded warrants, warrants and RSUs, which are included under the treasury stock method when dilutive. The calculation of diluted loss per share did not include options, liability classified pre-funded warrants, warrants and RSUs exercisable into 29,411,128 ordinary shares and 17,016,053 ordinary shares for the nine months ended September 30, 2026 and 2025, respectively, and 36,219,126 ordinary shares and 17,806,128 ordinary shares for the three months ended September 30, 2026 and 2025, respectively, because the effect would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="6"
      id="Fxbrl_20261106034404392"
      unitRef="NIS_per_Share">0.000025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20261106034742258"
      unitRef="shares">29411128</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250101to20250930"
      decimals="INF"
      id="Fxbrl_20261106034751351"
      unitRef="shares">17016053</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260701to20260930"
      decimals="INF"
      id="Fxbrl_20261106034805951"
      unitRef="shares">36219126</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250701to20250930"
      decimals="INF"
      id="Fxbrl_20261106034819764"
      unitRef="shares">17806128</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260802200536422">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;c.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0pt 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 1in;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Calibri, Helvetica, Sans-Serif;width:100%;border-collapse:separate"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:42.55pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:42.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Level 1:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Calibri, Helvetica, Sans-Serif;width:100%;border-collapse:separate"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:42.55pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:42.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Level 2:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Observable prices that are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font:10pt Calibri, Helvetica, Sans-Serif;width:100%;border-collapse:separate"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:42.55pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:42.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Level 3:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260501155135990">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;d.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Newly issued and recently adopted accounting pronouncements:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;i&gt;Recently issued accounting pronouncements not yet adopted&lt;/i&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 1in;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In November 2024, the FASB issued ASU&#160;2024-03 &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#x201d;, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 1in;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In December 2025, the FASB issued ASU 2025-10 &#x201c;Government Grants (Topic 832)&#x201d; to establish authoritative guidance on the accounting for government grants received by business entities. This update is effective beginning with the Company&#x2019;s 2029 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261031120931591">
    &lt;div&gt;
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;NOTE 3 - ISSUANCE OF ORDINARY SHARES, PRE-FUNDED WARRANTS AND WARRANTS&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;a.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;April 2026 Private Placement&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 1, 2026, the Company entered into a securities purchase agreement with certain funds affiliated with BVF Partners L.P. (collectively, &#x201c;BVF&#x201d;), providing for the private placement to BVF of an aggregate of 7,827,789 units (the &#x201c;2026 Units&#x201d;), each 2026 Unit consisting of (i) one ordinary share (or, in lieu thereof, one pre-funded warrant to purchase one ordinary share (the &#x201c;April 2026 Pre-Funded Warrants&#x201d;)) and (ii) one warrant to purchase one and one-half ordinary shares (the &#x201c;2026 Ordinary Share Warrants&#x201d;), for aggregate proceeds of approximately $10.0 million (or $1.2775 per 2026 Unit). On April 2, 2026, the Company issued 2,425,000 ordinary shares, 5,402,789 April 2026 Pre-Funded Warrants, and 11,741,683 2026 Ordinary Share Warrants in connection with this offering.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Each 2026 Ordinary Share Warrant has an exercise price of $1.24 per share, became exercisable on October 2, 2026, expires five years following the date of issuance, and is subject to customary adjustments. The 2026 Ordinary Share Warrants are exercisable only for cash so long as the Company has an effective registration statement registering the shares issuable upon exercise of the 2026 Ordinary Share Warrants. The 2026 Ordinary Share Warrants were classified as equity upon issuance, as they met the criteria for equity classification under ASC 815-40.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 31.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The April 2026 Pre-Funded Warrants were originally issued with an exercise price of NIS 0.0000769 per share, became exercisable upon issuance and have no expiration date. Prior to their reclassification to equity on August 21, 2026 (see Note 3c below), the April 2026 Pre-Funded Warrants were not considered indexed to the ordinary shares under ASC 815-40-15 and were classified as a financial liability measured at fair value (Level 2, based on the quoted share price), with changes in fair value recognized in financial expenses, net.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-top:0px;margin-bottom:0px"&gt;&lt;/div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The proceeds of the 2026 Private Placement were allocated first to the April 2026 Pre-Funded Warrants based on their fair value as of the closing date of $6.8 million (based on the closing share price of $1.26 on April 2, 2026), and the residual proceeds of $3.2 million were allocated to the ordinary shares.&lt;/span&gt;&lt;br/&gt;&#160;&lt;br/&gt;&lt;span&gt;The Company had issuance costs of approximately $171 thousand, of which $116 thousand allocated to the April 2026 Pre-Funded Warrants was recognized immediately in the statement of operations and the remaining portion allocated to the equity components was deducted from additional paid-in capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Through August 21, 2026, the pre-funded warrants liability was measured at fair value on a recurring basis based on the quoted price of the Company&#x2019;s ordinary shares (Level 2) based on the Company's share's market price less the nominal exercise price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the April 2026 Pre-Funded Warrants was $17.5 million as of August 21, 2026. Accordingly, the Company recognized a loss from the change in fair value of $7.9 million and $10.6 million for the three and nine months ended September 30, 2026, respectively. See also Note 3c.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;b.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;July 2026 Private Placement&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 26, 2026, in connection with the July 2026 Private Placement, the Company entered into a securities purchase agreement (the &#x201c;July 2026 Purchase Agreement&#x201d;) with certain institutional and accredited investors, including BVF, providing for the issuance and sale of an aggregate of 134,803,910 ordinary shares or, in lieu thereof, pre-funded warrants to purchase ordinary shares (the &#x201c;July 2026 Pre-Funded Warrants&#x201d;), at a purchase price of $2.04 per ordinary share, for aggregate gross proceeds of approximately $275.0 million. On July 28, 2026, the Company issued 122,961,215 ordinary shares and July 2026 Pre-Funded Warrants to purchase 11,842,695 ordinary shares. The Company incurred issuance costs of approximately $14.1 million, consisting of placement agent fees and legal expenses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The July 2026 Pre-Funded Warrants were originally issued with an exercise price of NIS 0.0000769 per ordinary share, became exercisable upon issuance, do not expire and are subject to customary beneficial ownership limitations and adjustments. As described in Note 3a above, the July 2026 Pre-Funded Warrants were originally classified as a financial liability measured at fair value, based on the market share price, until their reclassification to equity on August 21, 2026. See Note 3c below.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The proceeds of the July 2026 Private Placement were allocated first to the July 2026 Pre-Funded Warrants based on their fair value as of the closing date of $38.6 million (based on the closing share price of $3.26 on July 28, 2026), and the residual proceeds of $236.4 million were allocated to the ordinary shares. Issuance costs were allocated on the same basis: approximately $2.0 million allocated to the July 2026 Pre-Funded Warrants was recognized immediately in the statement of operations and $12.1 million allocated to the ordinary shares was deducted from additional paid-in capital.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the July 2026 Pre-Funded Warrants as of August 21, 2026, was approximately $38.3 million. Accordingly, the Company recognized income from the change in fair value of $355 thousand for the three and nine months ended September 30, 2026. See also Note 3c.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-top:0px;margin-bottom:0px"&gt;&lt;/div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective upon the closing of the July 2026 Private Placement, the Company granted BVF certain rights to designate two nominees to the Company&#x2019;s board of directors, subject to specified ownership thresholds and other conditions. In connection with the July 2026 Private Placement, the Company also agreed to submit to its shareholders an increase in the number of ordinary shares reserved under the 2018 Equity Incentive Plan (the &#x201c;2018 Plan&#x201d;) and certain equity awards to executive officers.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:7.1pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:35.45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;c.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;Amendment of the April 2026 and July 2026 Pre-Funded Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 21, 2026, the Company and BVF, the holder of all outstanding April 2026 and July 2026 Pre-Funded Warrants, amended the terms of such pre-funded warrants to change the exercise price from NIS 0.0000769 per ordinary share to $0.000025 per ordinary share. Following the amendment, the pre-funded warrants met the criteria for equity classification under ASC 815-40. In accordance with the standard, the pre-funded warrants were remeasured to fair value as of August 21, 2026, with the change in fair value recognized in financial expenses, net, and their fair value was reclassified from liability to additional paid-in capital. Following this amendment the pre-funded warrants no longer require remeasurement on a recurring basis as of the end of each reporting period. As of September 30, 2026, none of the April 2026 or July 2026 Pre-Funded Warrants had been exercised.&lt;br/&gt;&#160;&lt;br/&gt;Through August 21, 2026, the pre-funded warrant liability was measured at fair value on a recurring basis based on the quoted price of the Company&#x2019;s ordinary shares (Level 2).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table presents the changes in the pre-funded warrants liability (Level 2):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;div style="margin-left:42.55pt"&gt;

            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:93.5%"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="10" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;U.S. dollars in thousands&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial recognition at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,807&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,607&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,414&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:left;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value recognized in statement of operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,644&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(355&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;padding-bottom:1pt;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification to additional paid-in capital&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,451&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(38,252&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(55,703&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:left;padding-bottom:2.5pt;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of September 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20260401to20260401_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260804210542490"
      unitRef="shares">7827789</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260401to20260401_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20260501182344583"
      unitRef="USD">10000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20260401_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="4"
      id="Fxbrl_20260803182801816"
      unitRef="USD_per_Share">1.2775</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260501182501498"
      unitRef="shares">2425000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260501182903679"
      unitRef="shares">5402789</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260501182927054"
      unitRef="shares">11741683</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20260803003441125"
      unitRef="USD_per_Share">1.24</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="7"
      id="Fxbrl_20260803003538271"
      unitRef="NIS_per_Share">0.0000769</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261030173749679"
      unitRef="USD">6800000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20261030174021718"
      unitRef="USD_per_Share">1.26</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260402to20260402_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261030174055895"
      unitRef="USD">3200000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20261106041442263"
      unitRef="USD">171000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20261106041454042"
      unitRef="USD">116000</us-gaap:PaymentsOfStockIssuanceCosts>
    <entx:FairValueOfPreFundedWarrants
      contextRef="C_20260821_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041614431"
      unitRef="USD">17500000</entx:FairValueOfPreFundedWarrants>
    <entx:GainLossOnFairValueChangePreFundedWarrants
      contextRef="C_20260701to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041622141"
      unitRef="USD">-7900000</entx:GainLossOnFairValueChangePreFundedWarrants>
    <entx:GainLossOnFairValueChangePreFundedWarrants
      contextRef="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041631362"
      unitRef="USD">-10600000</entx:GainLossOnFairValueChangePreFundedWarrants>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20260701to20260731_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030175310084"
      unitRef="shares">134803910</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20260731_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20261030175458855"
      unitRef="USD_per_Share">2.04</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260701to20260731_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261030175527406"
      unitRef="USD">275000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030175544967"
      unitRef="shares">122961215</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030175716992"
      unitRef="shares">11842695</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261030175735417"
      unitRef="USD">14100000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="7"
      id="Fxbrl_20261030175753392"
      unitRef="NIS_per_Share">0.0000769</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041850745"
      unitRef="USD">38600000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20261106041859215"
      unitRef="USD_per_Share">3.26</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041909541"
      unitRef="USD">236400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260728to20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041918653"
      unitRef="USD">2000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <entx:FairValueOfPreFundedWarrants
      contextRef="C_20260728_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041927578"
      unitRef="USD">12100000</entx:FairValueOfPreFundedWarrants>
    <entx:FairValueOfPreFundedWarrants
      contextRef="C_20260821_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20261106041810189"
      unitRef="USD">38300000</entx:FairValueOfPreFundedWarrants>
    <entx:GainLossOnFairValueChangePreFundedWarrants
      contextRef="C_20260101to20260930_usgaapRelatedPartyTransactionAxis_entxInstitutionalAndAccreditedInvestorsMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20261106041818628"
      unitRef="USD">355000</entx:GainLossOnFairValueChangePreFundedWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260821_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="7"
      id="Fxbrl_20261030180931839"
      unitRef="NIS_per_Share">0.0000769</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260728_usgaapRelatedPartyTransactionAxis_entxBvfPartnersLpMember_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="6"
      id="Fxbrl_20261030181009751"
      unitRef="NIS_per_Share">0.000025</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <entx:ScheduleOfPreFundedWarrantsLiabilityActivityTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030182200465">
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:93.5%"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="10" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;U.S. dollars in thousands&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial recognition at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,807&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,607&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,414&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:left;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value recognized in statement of operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,644&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(355&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;padding-bottom:1pt;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification to additional paid-in capital&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,451&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(38,252&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(55,703&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:left;padding-bottom:2.5pt;width:64%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of September 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </entx:ScheduleOfPreFundedWarrantsLiabilityActivityTableTextBlock>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_22"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_25"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20261030182211743_28"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiabilityInitiallyRecognizedAtFairValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_33"
      unitRef="USD">6807000</entx:PreFundedWarrantsLiabilityInitiallyRecognizedAtFairValue>
    <entx:PreFundedWarrantsLiabilityInitiallyRecognizedAtFairValue
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_37"
      unitRef="USD">38607000</entx:PreFundedWarrantsLiabilityInitiallyRecognizedAtFairValue>
    <entx:PreFundedWarrantsLiabilityInitiallyRecognizedAtFairValue
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261030182211743_311"
      unitRef="USD">45414000</entx:PreFundedWarrantsLiabilityInitiallyRecognizedAtFairValue>
    <entx:GainLossOnPreFundedWarrantsLiability
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_43"
      unitRef="USD">10644000</entx:GainLossOnPreFundedWarrantsLiability>
    <entx:GainLossOnPreFundedWarrantsLiability
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_47"
      unitRef="USD">-355000</entx:GainLossOnPreFundedWarrantsLiability>
    <entx:GainLossOnPreFundedWarrantsLiability
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261030182211743_411"
      unitRef="USD">10289000</entx:GainLossOnPreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiabilityReclassifiedToAdditionalPaidInCapital
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_53"
      unitRef="USD">17451000</entx:PreFundedWarrantsLiabilityReclassifiedToAdditionalPaidInCapital>
    <entx:PreFundedWarrantsLiabilityReclassifiedToAdditionalPaidInCapital
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_57"
      unitRef="USD">38252000</entx:PreFundedWarrantsLiabilityReclassifiedToAdditionalPaidInCapital>
    <entx:PreFundedWarrantsLiabilityReclassifiedToAdditionalPaidInCapital
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261030182211743_511"
      unitRef="USD">55703000</entx:PreFundedWarrantsLiabilityReclassifiedToAdditionalPaidInCapital>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_entxApril2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_63"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_entxJuly2026PreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20261030182211743_67"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20261030182211743_611"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103191649815">
    &lt;div&gt;
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;NOTE 4 - EQUITY AND SHARE-BASED COMPENSATION&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.75in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Changes in Share Capital:&lt;br/&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 1, 2026, the Company issued 148,872 ordinary shares to five non-executive members of the board of directors in lieu of cash board fees for fiscal year 2025, which was approved by the Company&#x2019;s shareholders at a meeting of the Company&#x2019;s shareholders held on July 31, 2024. The fair value of the ordinary shares on the grant date was $289 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In February and April 2026, two former non-executive board members exercised options for an aggregate of 394,748 ordinary shares for total consideration of $260 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 14, 2026, the Company&#x2019;s shareholders approved an increase in the Company&#x2019;s authorized share capital to 350,000,000 ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 7, 2026, the Company issued 107,770 ordinary shares to five non-executive members of the board of directors in lieu of cash board fees for the first and second quarters of 2026, as approved by the Company&#x2019;s shareholders at a meeting held on July 31, 2024. The fair value of the ordinary shares on the grant date was $309 thousand. On August 5, 2026, the board of directors resolved to reinstate cash compensation for non-executive directors effective July 1, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;During the nine months ended September 30, 2026, certain holders of warrants issued in the Company&#x2019;s December 2023 private placement exercised an aggregate of 480,879 warrants and 906,886 pre-funded warrants &lt;/span&gt;for an aggregate of &lt;span&gt;1,387,765 ordinary shares, for aggregate gross proceeds to the Company of $474 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.75in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Share-based Compensation:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 11.25pt;text-indent:0.5in"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables summarizes option activity during the nine months ended September 30, 2026:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
          &lt;div style="margin-left:0pt"&gt;

              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="margin-left:54pt"&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td&gt;&#160;&lt;/td&gt;
                          &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                            &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nine months ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                          &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                            &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;Number of&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                          &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-align:left;text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning&lt;br/&gt;of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,283,274&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,849,312&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(410,308&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(93,137&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="padding-bottom:1pt;text-indent:-8.4pt;padding-left:8.4pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(411,112&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-align:left;padding-bottom:2.5pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,218,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.92&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-align:left;padding-bottom:2.5pt;text-indent:1.75pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,036,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
                &lt;p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/p&gt;
                &lt;div&gt;&lt;/div&gt;
                &lt;div style="margin-left:54pt"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td&gt;&#160;&lt;/td&gt;
                        &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                          &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three months ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="text-align:left;text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning&lt;br/&gt;of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,189,929&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;$&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069,787&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="padding-bottom:1pt;text-indent:-8.4pt;padding-left:8.4pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-align:left;padding-bottom:2.5pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,218,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;$&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.92&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="text-align:left;padding-bottom:2.5pt;text-indent:1.75pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,036,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-indent:0.5in"&gt;&#160;&lt;/p&gt;
      &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

          &lt;tr style="vertical-align:top"&gt;
            &lt;td style="width:0.75in"&gt;&lt;/td&gt;
            &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of each option granted was estimated as of the date of grant using the Black-Scholes option-pricing model, using the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
      &lt;div style="margin-left:54pt"&gt;

          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="padding-bottom:1pt;padding-left:0pt;width:86%"&gt;&#160;&lt;/td&gt;
                &lt;td style="font-weight:bold;padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:0.5pt solid black;font-weight:bold;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine months ended&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font-weight:bold;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37-$2.81&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:center;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84.2%-86.4%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.74%-4.42%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life - in years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5-6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

      &lt;/div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
      &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

          &lt;tr style="vertical-align:top"&gt;
            &lt;td style="width:0.75in"&gt;&lt;/td&gt;
            &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 7, 2026, the board of directors approved the grant of 734,428 RSUs to executive officers and service providers, of which 420,559 RSUs were subject to shareholder approval, which was obtained at a meeting of the Company&#x2019;s shareholders held on July 14, 2026. The RSUs vest in four equal quarterly installments over a one-year period that started on May 1, 2026. The fair value of the 313,869 RSUs that were not subject to shareholder approval was $430 thousand at the date of grant. The grant date for accounting purposes of the 420,559 RSUs subject to shareholder approval was July 14, 2026, and their fair value at the grant date was $681 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div&gt;
        &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;/div&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

          &lt;tr style="vertical-align:top"&gt;
            &lt;td style="width:0.75in"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="text-align:justify"&gt;
              &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In connection with the transactions contemplated by the July 2026 Private Placement, on September 16, 2026, the Company's Board of Directors approved one-time equity awards to the Company's Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief of Research and Development, consisting of 3,351,790 RSUs and 8,438,729 options to purchase an aggregate of 11,790,519 ordinary shares. The options have an exercise price of $2.96 per share and vest over three years, while the RSUs vest ratably on a quarterly basis over one year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0;margin-bottom:0"&gt;&#160;&lt;/p&gt;
              &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These equity awards are subject to shareholder approval at the Company's Special Meeting of Shareholders scheduled for November 24, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;p style="margin-top:0;margin-bottom:0"&gt;&#160;&lt;/p&gt;
      &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

          &lt;tr style="vertical-align:top"&gt;
            &lt;td style="width:0.75in"&gt;&lt;/td&gt;
            &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restricted shares units grants to employees and consultants:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.75in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;The following tables summarize information concerning RSUs:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 65.25pt;text-align:left"&gt;&#160;&lt;/p&gt;
      &lt;div style="margin-left:54pt"&gt;

          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="border-bottom:Black 1pt solid;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine Months Ended September&#160;30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="border-bottom:Black 1pt solid;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Three Months Ended September&#160;30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of RSU&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of RSU&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="width:52%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,984&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;313,870&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes during the period:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160; &#160; &#160; Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;991,070&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.72&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;528,329&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(559,510&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(267,655&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember"
      decimals="INF"
      id="Fxbrl_20231023161627495"
      unitRef="shares">148872</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember"
      decimals="-3"
      id="Fxbrl_20250802130737395"
      unitRef="USD">289000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260201to20260228_srtTitleOfIndividualAxis_entxFormerNonExecutiveBoardMember"
      decimals="INF"
      id="Fxbrl_20260501170216704"
      unitRef="shares">394748</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260201to20260228_srtTitleOfIndividualAxis_entxFormerNonExecutiveBoardMember"
      decimals="-3"
      id="Fxbrl_20260501171222343"
      unitRef="USD">260000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20260714"
      decimals="INF"
      id="Fxbrl_20261030151045455"
      unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260807to20260807_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember"
      decimals="INF"
      id="Fxbrl_20261030151104350"
      unitRef="shares">107770</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_20260807to20260807_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember"
      decimals="-3"
      id="Fxbrl_20261030151135629"
      unitRef="USD">309000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <entx:WarrantsExercisedDuringPeriod
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030152114844"
      unitRef="shares">480879</entx:WarrantsExercisedDuringPeriod>
    <entx:PreFundedWarrantsExercisedDuringPeriod
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030152218213"
      unitRef="shares">906886</entx:PreFundedWarrantsExercisedDuringPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030151923015"
      unitRef="shares">1387765</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20261030152254045"
      unitRef="USD">474000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103191722094">
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="margin-left:54pt"&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td&gt;&#160;&lt;/td&gt;
                          &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                            &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nine months ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                          &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                            &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;Number of&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                          &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-align:left;text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning&lt;br/&gt;of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,283,274&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,849,312&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(410,308&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(93,137&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="padding-bottom:1pt;text-indent:-8.4pt;padding-left:8.4pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(411,112&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                          &lt;td style="text-align:left;padding-bottom:2.5pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,218,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.92&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="vertical-align:bottom"&gt;
                          &lt;td style="text-align:left;padding-bottom:2.5pt;text-indent:1.75pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,036,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
                &lt;p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/p&gt;
                &lt;div&gt;&lt;/div&gt;
                &lt;div style="margin-left:54pt"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td&gt;&#160;&lt;/td&gt;
                        &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                          &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three months ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                        &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="text-align:left;text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning&lt;br/&gt;of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,189,929&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;$&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069,787&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-indent:-1.3pt;padding-left:1.3pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="padding-bottom:1pt;text-indent:-8.4pt;padding-left:8.4pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:1pt solid black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:1pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom"&gt;
                        &lt;td style="text-align:left;padding-bottom:2.5pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,218,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;$&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.92&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                        &lt;td style="text-align:left;padding-bottom:2.5pt;text-indent:1.75pt;width:76%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,036,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:left;width:1%"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="border-bottom:2.5pt double black;text-align:right;width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20261030141416069_23"
      unitRef="shares">9283274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20251231"
      decimals="2"
      id="Fxbrl_20261030141416069_27"
      unitRef="USD_per_Share">2.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20261030141416069_43"
      unitRef="shares">2849312</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20261030141416069_47"
      unitRef="USD_per_Share">1.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20261030141416069_53"
      unitRef="shares">410308</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20261030141416069_57"
      unitRef="USD_per_Share">0.7</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20261030141416069_63"
      unitRef="shares">93137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20261030141416069_67"
      unitRef="USD_per_Share">1.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_20260101to20260930"
      decimals="INF"
      id="Fxbrl_20261030141416069_73"
      unitRef="shares">411112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20261030141416069_77"
      unitRef="USD_per_Share">2.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20261030141416069_83"
      unitRef="shares">11218029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20261030141416069_87"
      unitRef="USD_per_Share">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20261030141416069_93"
      unitRef="shares">7036150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20261030141416069_97"
      unitRef="USD_per_Share">2.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20260630"
      decimals="INF"
      id="Fxbrl_20261030141705574_xbrl_20261030141416069_23"
      unitRef="shares">9189929</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20260630"
      decimals="2"
      id="Fxbrl_20261030141705574_xbrl_20261030141416069_27"
      unitRef="USD_per_Share">2.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260701to20260930"
      decimals="INF"
      id="Fxbrl_20261030141705576_xbrl_20261030141416069_43"
      unitRef="shares">2069787</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_20261030141705576_xbrl_20261030141416069_47"
      unitRef="USD_per_Share">1.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20260701to20260930"
      decimals="INF"
      id="Fxbrl_20261030141705577_xbrl_20261030141416069_53"
      unitRef="shares">15560</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_20261030141705577_xbrl_20261030141416069_57"
      unitRef="USD_per_Share">1.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20260701to20260930"
      decimals="INF"
      id="Fxbrl_20261030141705578_xbrl_20261030141416069_63"
      unitRef="shares">26127</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_20261030141705578_xbrl_20261030141416069_67"
      unitRef="USD_per_Share">1.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20261030141705579_xbrl_20261030141416069_83"
      unitRef="shares">11218029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20261030141705579_xbrl_20261030141416069_87"
      unitRef="USD_per_Share">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20261030141705580_xbrl_20261030141416069_93"
      unitRef="shares">7036150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20261030141705580_xbrl_20261030141416069_97"
      unitRef="USD_per_Share">2.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261031150849171">
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="padding-bottom:1pt;padding-left:0pt;width:86%"&gt;&#160;&lt;/td&gt;
                &lt;td style="font-weight:bold;padding-bottom:1pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:0.5pt solid black;font-weight:bold;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine months ended&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font-weight:bold;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37-$2.81&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:center;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84.2%-86.4%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.74%-4.42%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="text-align:left;padding-bottom:2.5pt;padding-left:0pt;width:86%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life - in years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="border-bottom:2.5pt double black;text-align:right;width:12%"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5-6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:2.5pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20260930_srtRangeAxis_srtMinimumMember"
      decimals="2"
      id="Fxbrl_20260803100451905"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20260930_srtRangeAxis_srtMaximumMember"
      decimals="2"
      id="Fxbrl_20260803100500085"
      unitRef="USD_per_Share">2.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20260502000751406_xbrl_20231023162308206"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_20260101to20260930_srtRangeAxis_srtMinimumMember"
      decimals="3"
      id="Fxbrl_20260803100534644"
      unitRef="Pure">0.842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_20260101to20260930_srtRangeAxis_srtMaximumMember"
      decimals="3"
      id="Fxbrl_20260803100540619"
      unitRef="Pure">0.864</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_20260101to20260930_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="Fxbrl_20260803100602533"
      unitRef="Pure">0.0374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_20260101to20260930_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="Fxbrl_20260803100613564"
      unitRef="Pure">0.0442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20260101to20260930_srtRangeAxis_srtMinimumMember"
      id="Fxbrl_20250802122622298">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20260101to20260930_srtRangeAxis_srtMaximumMember"
      id="Fxbrl_20260805010332428">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20260507to20260507_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20260803120306259"
      unitRef="shares">734428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <entx:RestrictedSharesUnitsSubjectToShareholderApproval
      contextRef="C_20260714to20260714_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030152459748"
      unitRef="shares">420559</entx:RestrictedSharesUnitsSubjectToShareholderApproval>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20260501to20260501_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="Fxbrl_20261030153153557">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20260501to20260501_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030152720516"
      unitRef="shares">313869</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260501to20260501_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fxbrl_20261031114714464"
      unitRef="USD">430000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <entx:RestrictedSharesUnitsSubjectToShareholderApproval
      contextRef="C_20260714to20260714_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030152647660"
      unitRef="shares">420559</entx:RestrictedSharesUnitsSubjectToShareholderApproval>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260714to20260714_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fxbrl_20261030152753974"
      unitRef="USD">681000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260916to20260916_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030153251133"
      unitRef="shares">3351790</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20260916to20260916_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20261103155421453"
      unitRef="USD">8438729000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260916to20260916_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20261030153335165"
      unitRef="shares">11790519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260916to20260916_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20261030153351389"
      unitRef="USD_per_Share">2.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20260916to20260916_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      id="Fxbrl_20261030153412644">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261031150901308">
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, serif;width:94.6%"&gt;

                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="border-bottom:Black 1pt solid;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine Months Ended September&#160;30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="border-bottom:Black 1pt solid;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Three Months Ended September&#160;30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of RSU&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of RSU&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="width:52%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,984&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;313,870&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes during the period:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160; &#160; &#160; Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;991,070&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.72&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;528,329&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(559,510&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(267,655&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20251231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_53"
      unitRef="shares">142984</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20251231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_57"
      unitRef="USD_per_Share">2.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20260630_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_511"
      unitRef="shares">313870</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20260630_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_515"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_73"
      unitRef="shares">991070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_77"
      unitRef="USD_per_Share">1.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20260701to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_711"
      unitRef="shares">528329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20260701to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_715"
      unitRef="USD_per_Share">1.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_83"
      unitRef="shares">559510</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_87"
      unitRef="USD_per_Share">1.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20260701to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_811"
      unitRef="shares">267655</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20260701to20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_815"
      unitRef="USD_per_Share">2.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_93"
      unitRef="shares">574544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_97"
      unitRef="USD_per_Share">1.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20261030145431711_911"
      unitRef="shares">574544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20261030145431711_915"
      unitRef="USD_per_Share">1.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <entx:SupplementaryFinancialStatementInformationTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260503143049801">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;NOTE 5 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance sheets:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;September 30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other current assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:76%;text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,778&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:left;padding-left:11.65pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#160;Receivable in respect of collaborative arrangement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;padding-left:11.65pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#160;VAT receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;padding-bottom:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#160;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;182&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:justify;padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4,046&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;September 30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accrued expenses and other payables:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:76%;text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Employees and employees related&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;343&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Provision for vacation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;211&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Payables in respect of collaborative arrangement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;325&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;316&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;726&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:justify;padding-bottom:1pt;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other payables (See Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,540&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </entx:SupplementaryFinancialStatementInformationTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250802053612224">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;September 30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other current assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:76%;text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,778&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:left;padding-left:11.65pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#160;Receivable in respect of collaborative arrangement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;padding-left:11.65pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#160;VAT receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;padding-bottom:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#160;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;182&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:justify;padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4,046&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103184253066_xbrl_20230731132636236_xbrl_20220808200953075_xbrl_20220510112546992"
      unitRef="USD">3778000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184253066_xbrl_20230731132636236_xbrl_20220808200953075_xbrl_20220510112707928"
      unitRef="USD">37000</us-gaap:PrepaidExpenseCurrent>
    <entx:ReceivableInRespectOfCollaborativeArrangement
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20260501160205431_xbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112644305"
      unitRef="USD">0</entx:ReceivableInRespectOfCollaborativeArrangement>
    <entx:ReceivableInRespectOfCollaborativeArrangement
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20260501160205431_xbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">219000</entx:ReceivableInRespectOfCollaborativeArrangement>
    <us-gaap:ValueAddedTaxReceivable
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20260804212156505"
      unitRef="USD">86000</us-gaap:ValueAddedTaxReceivable>
    <us-gaap:ValueAddedTaxReceivable
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20260804212206056"
      unitRef="USD">52000</us-gaap:ValueAddedTaxReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112644305"
      unitRef="USD">182000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">107000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103184311257_xbrl_20240506181323372_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112644305"
      unitRef="USD">4046000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184311257_xbrl_20240506181323372_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">415000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250802053632508">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;September 30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accrued expenses and other payables:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:76%;text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Employees and employees related&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;343&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Provision for vacation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;211&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:left;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Payables in respect of collaborative arrangement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;325&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;316&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;726&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="text-align:justify;padding-bottom:1pt;text-indent:14.2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other payables (See Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="text-align:justify;padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,540&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103184257516_xbrl_20220808200953075_xbrl_20220510112546992"
      unitRef="USD">343000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184257516_xbrl_20220808200953075_xbrl_20220510112707928"
      unitRef="USD">264000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250505224747238"
      unitRef="USD">211000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184257519_xbrl_20220808200953079_xbrl_20220510112732615"
      unitRef="USD">168000</us-gaap:AccruedVacationCurrent>
    <entx:PayableInRespectOfCollaborativeArrangement
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20261030180210367_xbrl_20250505224747238"
      unitRef="USD">325000</entx:PayableInRespectOfCollaborativeArrangement>
    <entx:PayableInRespectOfCollaborativeArrangement
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20261030180210367_xbrl_20241103184257519_xbrl_20220808200953079_xbrl_20220510112732615"
      unitRef="USD">0</entx:PayableInRespectOfCollaborativeArrangement>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20260802200918728"
      unitRef="USD">316000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184257522_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">726000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20250505224654542"
      unitRef="USD">345000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250505224704400"
      unitRef="USD">367000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20260930"
      decimals="-3"
      id="Fxbrl_20241103184306289_xbrl_20220808200953083_xbrl_20220510112657784"
      unitRef="USD">1540000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184306289_xbrl_20220808200953083_xbrl_20220510112751072"
      unitRef="USD">1525000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260501172305655">
    &lt;div&gt;
      &lt;div&gt;
        &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 6 - COLLABORATION AND RESEARCH AGREEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:left"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 16, 2025, the Company entered into a collaboration agreement with OPKO (the &#x201c;2025 Collaboration Agreement&#x201d;), which is accounted for as a collaboration arrangement within the scope of ASC 808.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the terms of the 2025 Collaboration Agreement, the Company and OPKO have agreed to collaborate with respect to the preclinical and clinical development and decision making related to the&#160;&lt;span&gt;EB618 Program.&#160;The Company and OPKO share in the economics and development costs of such program at 40% and 60%, respectively, subject to certain opt-out provisions.&lt;/span&gt; In connection with the agreement, the Company issued 3,685,226 ordinary shares to OPKO for aggregate gross proceeds of $8.0 million, which were allocated between equity and the collaboration components of the arrangement. Amounts allocated to the collaboration component are recognized over the period of performance and presented within other liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 3, 2026, the Company and OPKO amended and restated the 2025 Collaboration Agreement (the &#x201c;A&amp;amp;R Collaboration Agreement&#x201d;) to expand the scope of the collaboration to include the EB612 Program. Development costs and proceeds related to the EB612 Program are shared equally between the parties. Except for the foregoing expansion, the material terms of the 2025 Collaboration Agreement remain unchanged.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the three and nine months ended September 30, 2026, the Company recognized net expenses of $655 thousand and $1.8 million, respectively, relating to the A&amp;amp;R Collaboration Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementNatureAndPurpose
      contextRef="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      id="Fxbrl_20250505233528450">Company and OPKO have agreed to collaborate with respect to the preclinical and clinical development and decision making related to the&#160;</us-gaap:CollaborativeArrangementNatureAndPurpose>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="INF"
      id="Fxbrl_20250505233547681"
      unitRef="shares">3685226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="-5"
      id="Fxbrl_20250505233604451"
      unitRef="USD">8000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OperatingExpenses
      contextRef="C_20260701to20260930_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="-3"
      id="Fxbrl_20250802065759982"
      unitRef="USD">655000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20260101to20260930_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="-5"
      id="Fxbrl_20260802201500526"
      unitRef="USD">1800000</us-gaap:OperatingExpenses>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260503150859901">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;NOTE 7 &#x2013; SEGMENT INFORMATION&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company is legally headquartered, and the Company&#x2019;s laboratories are located,&#160;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span&gt;in Israel as a &lt;span style="-sec-ix-hidden:Fxbrl_20260804213855092"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20260804213019803"&gt;single&lt;/span&gt;&lt;/span&gt; operating segment. The Company&#x2019;s Chief Executive Officer is the chief operating decision maker (the &#x201c;CODM&#x201d;). The CODM makes decisions on resource allocation, assesses performance of the business and monitors budget versus actual results on a consolidated basis. The CODM reviews the Company's consolidated results of operations through income (loss) before income taxes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"&gt;

            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.75in"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment information:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;div style="margin-left:0.75in"&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif"&gt;

                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nine Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="width:52%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="font-style:italic;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development, net:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical trial, sub-contractors and consulting expense (EB613)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,161&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,827&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;572&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net expenses related to OPKO Collaboration Agreement&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,819&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;190&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;655&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payroll and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,546&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,184&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;627&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,331&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;799&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;641&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;344&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;157&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other development expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;111&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;136&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-bottom:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other segment expenses*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,037&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,672&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,557&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-bottom:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment net loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,414&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,597&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* Other segment expenses mainly related to general and administrative expenses, including payroll and related expenses, share-based compensation, legal and audit fees and others, and to financial expenses (income), net, including changes in the fair value of the pre-funded warrants liability.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261031124840394">The Company&#x2019;s Chief Executive Officer is the chief operating decision maker (the &#x201c;CODM&#x201d;).</us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260802201928935">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif"&gt;

                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nine Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;p style="margin-top:0;margin-bottom:0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="width:52%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="font-style:italic;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development, net:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical trial, sub-contractors and consulting expense (EB613)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,161&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,827&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;572&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net expenses related to OPKO Collaboration Agreement&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,819&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;190&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;655&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payroll and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,546&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,184&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;627&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,331&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;799&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;641&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;344&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;157&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-left:14.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other development expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;111&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;136&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="text-align:left;padding-bottom:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other segment expenses*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,037&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,672&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 1pt solid;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,557&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="text-align:left;padding-bottom:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment net loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,414&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,597&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:Black 2.5pt double;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="padding-bottom:2.5pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* Other segment expenses mainly related to general and administrative expenses, including payroll and related expenses, share-based compensation, legal and audit fees and others, and to financial expenses (income), net, including changes in the fair value of the pre-funded warrants liability.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144884_xbrl_20250802133250157_211"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144884_xbrl_20250802133250157_215"
      unitRef="USD">42000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_211"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_215"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20261030175214454_xbrl_20260802202144890_xbrl_20250802133250157_63"
      unitRef="USD">5161000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20261030175214454_xbrl_20260802202144890_xbrl_20250802133250157_611"
      unitRef="USD">1544000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20261030175214454_xbrl_20250802133250157_63"
      unitRef="USD">2827000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20261030175214454_xbrl_20250802133250157_611"
      unitRef="USD">572000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144890_xbrl_20250802133250157_63"
      unitRef="USD">1819000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144890_xbrl_20250802133250157_611"
      unitRef="USD">190000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_63"
      unitRef="USD">655000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_611"
      unitRef="USD">70000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144892_xbrl_20250802133250157_711"
      unitRef="USD">1546000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144892_xbrl_20250802133250157_715"
      unitRef="USD">1184000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_711"
      unitRef="USD">627000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_715"
      unitRef="USD">418000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144895_xbrl_20250802133250157_811"
      unitRef="USD">1331000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144895_xbrl_20250802133250157_815"
      unitRef="USD">799000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_811"
      unitRef="USD">641000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_815"
      unitRef="USD">329000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144897_xbrl_20250802133250157_911"
      unitRef="USD">409000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144897_xbrl_20250802133250157_915"
      unitRef="USD">344000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_911"
      unitRef="USD">157000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_915"
      unitRef="USD">118000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherExpenses
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144899_xbrl_20250802133250157_1011"
      unitRef="USD">111000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144899_xbrl_20250802133250157_1015"
      unitRef="USD">225000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_1011"
      unitRef="USD">18000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_1015"
      unitRef="USD">136000</us-gaap:OtherExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
      unitRef="USD">16037000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
      unitRef="USD">4179000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_1111"
      unitRef="USD">10672000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_1115"
      unitRef="USD">1557000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="-3"
      id="Fxbrl_20260802202144904_xbrl_20250802133250157_1211"
      unitRef="USD">-26414000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="-3"
      id="Fxbrl_20260802202144904_xbrl_20250802133250157_1215"
      unitRef="USD">-8423000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="-3"
      id="Fxbrl_20250802133250157_1211"
      unitRef="USD">-15597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="-3"
      id="Fxbrl_20250802133250157_1215"
      unitRef="USD">-3200000</us-gaap:NetIncomeLoss>
    <ecd:MtrlTermsOfTrdArrTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103153111390">
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the quarter ended September 30, 2026, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any &#x201c;non-Rule 10b5-1 trading arrangement&#x201d;, as defined in Item 408 of Regulation S-K.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndTitle
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103153152829">officers or directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103153337613">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103153210779">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103153410464">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261103153256454">false</ecd:Rule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20250802133250157_1111"
          xlink:label="Fxbrl_20250802133250157_1111"
          xlink:type="locator"/>
        <link:footnote id="FN20261030175043361" xlink:label="FN20261030175043361" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other segment expenses mainly related to general and administrative expenses, including payroll and related expenses, share-based compensation, legal and audit fees and others, and to financial expenses (income), net, including changes in the fair value of the pre-funded warrants liability.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802133250157_1111"
          xlink:to="FN20261030175043361"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802133250157_1115"
          xlink:label="Fxbrl_20250802133250157_1115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802133250157_1115"
          xlink:to="FN20261030175043361"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
          xlink:label="Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
          xlink:to="FN20261030175043361"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
          xlink:label="Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
          xlink:to="FN20261030175043361"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnote id="FN20250802115348372" xlink:label="FN20250802115348372" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount less than one thousand U.S. dollars.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:label="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20251107164113212"
          xlink:label="Fxbrl_20251107164113212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20251107164113212"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261031104953773_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261031105005821_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261031105012763_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261031105015786_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261031105423495_xbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261031105446192_xbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20261106032913895"
          xlink:label="Fxbrl_20261106032913895"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20261106032913895"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
